Reuters logo
a year ago
BRIEF-Anavex confirms data from Phase 2a study of ANAVEX 2-73 in Alzheimer's patients presented at AAIC 2016
July 29, 2016 / 1:26 PM / a year ago

BRIEF-Anavex confirms data from Phase 2a study of ANAVEX 2-73 in Alzheimer's patients presented at AAIC 2016

July 29 (Reuters) - Anavex Life Sciences Corp :

* Anavex "remains dedicated" to advancing ANAVEX 2-73 and will be reporting new data to investors as it becomes available

* Anavex confirms data from phase 2a study of ANAVEX 2-73 in alzheimer's patients presented at AAIC 2016

* Anavex confirms that there has been no change with regards to its science, data or fundamentals of company Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below